首页 产品目录 分子砌块 按应用领域 分子与化学生命科学 生化试剂 药物研究试剂 异丁酸2-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-环己基-7-羟基-6a,8a-二甲基-4-氧代-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-十二氢-8bH-萘并[2',1':4,5]茚并[1,2-d][1,3]二氧杂环戊烯-8b-基)-2-氧代乙酯

异丁酸2-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-环己基-7-羟基-6a,8a-二甲基-4-氧代-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-十二氢-8bH-萘并[2',1':4,5]茚并[1,2-d][1,3]二氧杂环戊烯-8b-基)-2-氧代乙酯

2-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-cyclohexyl-7-hydroxy-6a,8a-dimethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl isobutyrate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

126544-47-6

中文名称

异丁酸2-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-环己基-7-羟基-6a,8a-二甲基-4-氧代-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-十二氢-8bH-萘并[2',1':4,5]茚并[1,2-d][1,3]二氧杂环戊烯-8b-基)-2-氧代乙酯

英文名称

2-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-cyclohexyl-7-hydroxy-6a,8a-dimethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl isobutyrate

别名

Alvesco 160 | Ciclesonida | CICLESONIDE [EP MONOGRAPH] | SCHEMBL3688 | E83CFZ7SZD | Omnaris HFA | UNII-S59502J185 | CCG-269962 | (11?,16?)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)pregna-1,4-diene-3,20-dione | C3701 |

标准英文名

2-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-cyclohexyl-7-hydroxy-6a,8a-dimethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl isobutyrate

MDL No.

MFCD00866004

分子式

C32H44O7

分子量

540.70

精确分子量

540.31

SMILES

CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C

标准SMILES

CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]21C)C1CCCCC1

用途

Ciclesonide is a novel inhaled corticosteroid used for the treatment of asthma; it is administered in an inactive form and is activated locally in the airways by endogenous esterases to its active metabolite, demonstrating high local anti-inflammatory activity. It is indicated for the treatment of persistent asthma of all severity levels in adults, administered once daily at doses of 80 µg or 160 µg. In patients with severe asthma at risk of exacerbations who require potent anti-inflammatory therapy, the dose may be increased to 160 µg. Ciclesonide exhibits favorable pharmacokinetic properties that reduce both local and systemic adverse effects while maintaining high anti-asthmatic efficacy, significantly decreasing the need for oral corticosteroids (OCS) and thus serving as an effective OCS-sparing therapy. It is also used for the treatment of obstructive airway diseases.

InChIKey

LUKZNWIVRBCLON-GXOBDPJESA-N

安全信息

SureRoute逆合成路线

1.  126544-47-6 逆合成路线 1

—
—
ACCYFV637
126544-47-6
来源: SureRoute

2.  126544-47-6 逆合成路线 2

—
—
ACCYFV637
126544-47-6
来源: SureRoute

3.  126544-47-6 逆合成路线 3

ACNTZO893
5534-09-8
—
—
ACCYFV637
126544-47-6
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手